Summary & Overview
HCPCS G0033: Multiple Benzodiazepine Prescriptions for High-Risk Diagnoses
HCPCS Level II code G0033 flags occurrences where two or more benzodiazepine prescriptions were ordered for patients with specific high-risk diagnoses, including seizure disorders, REM sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder. Nationally, this code helps monitor and measure potentially risky prescribing patterns and supports quality oversight for populations vulnerable to adverse events from benzodiazepines.
Key payers included in this review are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context behind the code, the typical service settings where the code may be documented, and the implications for quality measurement and utilization monitoring. The publication outlines common benchmarks used in payer and plan-level reviews, recent policy shifts affecting benzodiazepine prescribing surveillance, and practical coding considerations relevant to billing and reporting workflows.
Data not available in the input is noted where applicable; the focus remains on explaining the code's purpose, the patient diagnoses it applies to, and the service context in which it is used.
Billing Code Overview
HCPCS Level II code G0033 identifies instances where two or more benzodiazepine prescriptions were ordered for patients who had a qualifying diagnosis on or between January 1 of the year prior to the measurement period and the IPSD for benzodiazepines. The listed qualifying diagnoses include seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder.
Service type: Medication management / prescription monitoring for benzodiazepines.
Typical site of service: Outpatient clinic, behavioral health clinic, primary care setting, or pharmacy-managed medication review.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a documented history of generalized anxiety disorder and prior REM sleep behavior disorder presents for medication management. The clinician reviews the medication list and electronic prescription history and identifies that the patient has received two or more benzodiazepine prescriptions during the measurement period. The clinical workflow includes: medication reconciliation during an office visit or telehealth encounter, chart review for diagnoses between January 1 of the year prior to the measurement period and the index prescription service date, confirmation of relevant diagnoses in the problem list (for example, seizure disorder, REM sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder), documentation of indication and rationale in the medical record, and submission of the HCPCS Level II code G0033 for quality measurement/reporting purposes. Typical settings include outpatient primary care clinics, neurology or psychiatry clinics, sleep disorder centers, and behavioral health clinics where prescribing and medication review occur.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When work required is substantially greater than typically required and documented for a visit during which benzodiazepine management or complex medication reconciliation is provided. |